Global leader in photodynamic technology.
To improve patient care and quality of life by making solutions based on photodynamic technology accessible to patients worldwide.
Photocure has a strong academic network and has a proven track record in development, registration and commercialization of our products: Metvix® and Hexvix®/Cysview®.
Key elements of the company strategy are:
- Build a speciality pharma company, focused on selected therapeutic areas
- Maximize the potential of the company's Photodynamic Technology Platform – Photocure Technology®
- Leverage our experience to develop, register and commercialize new products based on Photocure Technology®
- Build a strong commercial platform in select territories